FPTB, a novel CA-4 derivative, induces c
β
Ju-Fang Liu; Yi-Chin Fong; Kai-Wei Chang; Sheng-Chu Kuo; Chih-Shiang Chang; Chih
π
Article
π
2011
π
John Wiley and Sons
π
English
β 364 KB
## Abstract Chondrosarcoma is a malignant primary bone tumor that responds poorly to both chemotherapy and radiation therapy. The aim of this study was to elucidate the mechanism of the novel Combretastatin Aβ4 derivative, 2β(furanyl)β5β(pyrrolidinyl)β1β(3,4,5βtrimethoxybenzyl)benzoimidazole (FPTB)